
51 - 200 employees
Founded 2011
𧬠Biotechnology
π€ Artificial Intelligence
π Pharmaceuticals
Biotechnology β’ Artificial Intelligence β’ Pharmaceuticals
Absci is a biotechnology company that uses generative artificial intelligence together with wet-lab validation to design de novo biologics, primarily antibodies. Its integrated AI Drug Creation Platform performs data generation, model training, de novo design, multi-parametric lead optimization, and AI-enabled target discovery (using reverse immunology) to uncover novel antibody/target pairs and accelerate IND-enabling studies. Absci advances internal and partnered therapeutic programsβsuch as ABS-201, a designed antibody targeting prolactin receptors for androgenetic alopeciaβand emphasizes rapid iterative cycles between AI and lab work to shorten biologics discovery timelines.
π₯ 7 minutes ago
VP of Clinical Development leading clinical research strategies at Absci, a biotechnology company. Overseeing clinical trials, regulatory strategies, and cross-functional collaborations.
π½ New York, Washington β Remote
π΅ $355k - $390k / year
β° Full Time
π΄ Lead
π Vice President
π₯ 7 minutes ago
Senior Clinical Trial Manager independently managing Phase I clinical trials at Absci. Overseeing operational execution and collaboration with CROs, vendors, and internal teams.